BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11207192)

  • 1. Expression of Fas/Fas ligand by decidual leukocytes in hydatidiform mole.
    Wongweragiat S; Searle RF; Bulmer JN
    Biol Reprod; 2001 Mar; 64(3):784-9. PubMed ID: 11207192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence for apoptosis of decidual leucocytes in normal and molar pregnancy: implications for immune privilege.
    Pongcharoen S; Bulmer JN; Searle RF
    Clin Exp Immunol; 2004 Nov; 138(2):330-6. PubMed ID: 15498045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy.
    Pongcharoen S; Searle RF; Bulmer JN
    Placenta; 2004 Apr; 25(4):321-30. PubMed ID: 15028424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decidual T lymphocyte activation in hydatidiform mole.
    Wongweragiat S; Searle RF; Bulmer JN
    J Clin Pathol; 1999 Dec; 52(12):888-94. PubMed ID: 10711251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decidual immune cell infiltrate in hydatidiform mole.
    Hussein MR; Abd-Elwahed AR; Abodeif ES; Abdulwahed SR
    Cancer Invest; 2009 Jan; 27(1):60-6. PubMed ID: 19160109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decidual infiltration of FoxP3⁺ regulatory T cells, CD3⁺ T cells, CD56⁺ decidual natural killer cells and Ki-67 trophoblast cells in hydatidiform mole compared to normal and ectopic pregnancies.
    Sundara YT; Jordanova ES; Hernowo BS; Gandamihardja S; Fleuren GJ
    Mol Med Rep; 2012 Jan; 5(1):275-81. PubMed ID: 22002546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas ligand expression by maternal decidual cells is negatively correlated with the abundance of leukocytes present at the maternal-fetal interface.
    Qiu Q; Yang M; Tsang BK; Gruslin A
    J Reprod Immunol; 2005 Apr; 65(2):121-32. PubMed ID: 15811517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of leukemia inhibitory factor and insulin like growth factor-1 between normal pregnancies, partial hydatidiform moles and complete hydatidiform moles.
    Yucel Cicek OS; Hekimoglu ER; Turgal M; Atilla P; Cakar AN; Usubutun A; Beksac MS
    Placenta; 2018 Sep; 69():64-70. PubMed ID: 30213486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system.
    Kayisli UA; Selam B; Guzeloglu-Kayisli O; Demir R; Arici A
    J Immunol; 2003 Sep; 171(5):2305-13. PubMed ID: 12928375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease.
    Mor G; Gutierrez LS; Eliza M; Kahyaoglu F; Arici A
    Am J Reprod Immunol; 1998 Aug; 40(2):89-94. PubMed ID: 9764350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of laminin receptor 1 on decidual cells in partial and complete mole.
    Nagymanyoki Z; Callahan MJ; Parast MM; Berkowitz RS; Mok SC; Fulop V
    Gynecol Oncol; 2008 Jan; 108(1):121-5. PubMed ID: 17928039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of RCAS1 immunoreactivity within hydatidiform mole cells and decidual cells according to the applied therapeutic strategy: surgery or surgery followed by chemotherapy.
    Wicherek L; Basta P; Wertel I; Kojs Z; Malkowski B; Grabiec M; Pietrus M; Krystyna G
    Gynecol Obstet Invest; 2012; 73(2):106-12. PubMed ID: 22269478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of immunosuppressive properties of hydatidiform mole decidua and trophoblast extracts.
    Bennett WA; Brackin MN; Long CA; Cowan BD
    Am J Reprod Immunol; 1996 Aug; 36(2):86-9. PubMed ID: 8862251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
    Hussein MR
    Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of immunocompetent cells in decidua of controlled and uncontrolled (choriocarcinoma/hydatidiform mole) trophoblast invasion.
    Knoeller S; Lim E; Aleta L; Hertwig K; Dudenhausen JW; Arck PC
    Am J Reprod Immunol; 2003 Jul; 50(1):41-7. PubMed ID: 14506927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of functional Fas ligand in choriocarcinoma.
    Hammer A; Hartmann M; Sedlmayr P; Walcher W; Kohnen G; Dohr G
    Am J Reprod Immunol; 2002 Oct; 48(4):226-34. PubMed ID: 12516633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas and Fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy.
    Hammer A; Blaschitz A; Daxböck C; Walcher W; Dohr G
    Am J Reprod Immunol; 1999 Jan; 41(1):41-51. PubMed ID: 10097786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical studies of fetal trophoblast and maternal decidua in hydatidiform mole and choriocarcinoma.
    Bulmer JN; Johnson PM; Sasagawa M; Takeuchi S
    Placenta; 1988; 9(2):183-200. PubMed ID: 3041405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemistry of p57 and p53 protein in differential diagnosis of hydropic abortion, partial and complete hydatidiform mole].
    Chen YX; Shen DH; Gu YQ; Zhong PP; Xie JL; Song QJ; Zhang YL; Wen J
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):694-7. PubMed ID: 22321550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal growth restriction is associated with reduced FasL expression by decidual cells.
    Eide IP; Isaksen CV; Salvesen KA; Langaas M; Günther CC; Iversen AC; Austgulen R
    J Reprod Immunol; 2007 Jun; 74(1-2):7-14. PubMed ID: 17196256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.